MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 31, 2004; DOI: 10.1124/mol.104.002634


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002634v1
66/6/1415    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokochi, T.
Right arrow Articles by Robertson, K. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokochi, T.
Right arrow Articles by Robertson, K. D


Received for publication May 12, 2004.
Revised August 11, 2004.
Accepted for publication August 27, 2004.

Doxorubicin inhibits DNMT1 resulting in conditional apoptosis

Tomoki Yokochi 1 Keith D Robertson 2*

1 National Cancer Institute / NIH 2 University of Florida

* Address correspondence to: E-mail: keithr{at}ufl.edu

Abstract

Chemotherapy utilizing DNA intercalators is one of the most successful approaches to cancer treatment. Although DNA intercalators are believed to inhibit DNA polymerases and topoisomerases resulting in the induction of apoptosis in tumor cells, other factors potentially inhibited by the anthracycline antibiotics remain to be elucidated. Here we show that the enzymatic activity of DNMT1, the primary DNA methyltransferase in mammalian cells, is inhibited by DNA intercalators such as doxorubicin in an in vitro assay. Enzymatic analyses indicate that doxorubicin inhibits the catalytic activity of DNMT1 via DNA intercalation. We also found that apoptosis was induced in DNMT1+/+ HCT116 cells by only a limited range of doxorubicin dose, meaning that apoptotic cell death is "conditional" with respect to the concentration of the DNA intercalating drug. Interestingly, conditional apoptosis is not observed in human colorectal cancer cells lacking DNMT1 but can be induced in DNMT1-/- cells by transfection of a plasmid expressing DNMT1. Our results suggest that DNMT1 is one of the major targets of doxorubicin resulting in drug-induced apoptosis in human cancer cells. We propose that expression levels of DNMT1 in tumor cells may affect the effectiveness of doxorubicin in chemotherapy.


Key words: Enzymology, Apoptosis, DNA damage and repair, Mechanisms of cell killing/apoptosis, DNA intercalation


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. Zhou, M. Liu, Y. Zhai, and W. Xie
The Antiapoptotic Role of Pregnane X Receptor in Human Colon Cancer Cells
Mol. Endocrinol., April 1, 2008; 22(4): 868 - 880.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Kundakovic, Y. Chen, E. Costa, and D. R. Grayson
DNA Methyltransferase Inhibitors Coordinately Induce Expression of the Human Reelin and Glutamic Acid Decarboxylase 67 Genes
Mol. Pharmacol., March 1, 2007; 71(3): 644 - 653.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Levenson
DNA (Cytosine-5) Methyltransferase Inhibitors: A Potential Therapeutic Agent for Schizophrenia
Mol. Pharmacol., March 1, 2007; 71(3): 635 - 637.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Veldic, A. Guidotti, E. Maloku, J. M. Davis, and E. Costa
In psychosis, cortical interneurons overexpress DNA-methyltransferase 1
PNAS, February 8, 2005; 102(6): 2152 - 2157.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics